Dasatinib is superior to imatinib in adult Ph + ALL: a propensity score-matched analysis of pooled JALSG trial data. Nishiwaki S, Sugiura I, Fujisawa S, Hatta Y, et al. Int J Hematol 2026;123:24-31.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nishiwaki S, Sugiura I, Fujisawa S, Hatta Y, et al. Dasatinib is superior to imatinib in adult Ph + ALL: a propensity score-matched analysis of pooled JALSG trial data. Int J Hematol 2026;123:24-31.
PMID: 40864405